Streetbeat News

Products Services

DKNG

Financial analysts have observed a bearish trend in DraftKings (NASDAQ:DKNG) options trading, with a significant number of trades indicating a bearish sentiment despite some bullish activity. The trading activity suggests a target price range of $40.0 to $45.0 for DraftKings in the coming months. DraftKings, a leader in online sports and casino gambling, is currently live with online sports betting in 24 states and iGaming in seven states. Despite the bearish options sentiment, market experts have issued positive ratings for DKNG, with a consensus target price of $55.2.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:00 pm

PFE

Pfizer (NYSE:PFE) has seen a significant amount of options trading activity, with a bullish sentiment from the majority of investors. Analysis of 17 trades shows a preference for calls over puts, indicating expectations of a price increase. The trading activity suggests a price target range between $18.0 and $44.0. Recent analyst ratings have varied, with an average target price of $42.0. Pfizer's current market status shows a slight price increase with potential overbought indicators. The company's financial health remains strong, with a diverse portfolio of prescription drugs and vaccines.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:00 pm

EWU

PFE

The UK's Medicines and Healthcare products Regulatory Agency has approved Etrasimod for treating patients over 16 with Ulcerative Colitis, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 3:00 pm

MSFT

NVDA

Wedbush analyst Dan Ives highlighted the significant impact of Nvidia's H100 GPU on tech spending, suggesting every $1 spent on the GPU could lead to an additional $10-$12 in tech ecosystem spending. This reflects the broader AI revolution's influence on tech investments. Ives previously noted Nvidia's Q4 results as the beginning of an AI spending wave. Meanwhile, Microsoft's CEO emphasized the rapid AI adoption across sectors, and ARK's Cathie Wood expressed concerns over a potential semiconductor market correction.

Portfolio Pulse from Rounak Jain

March 11, 2024 | 3:00 pm

VTRS

Viatris (VTRS) and its partner Mapi Pharma received a Complete Response Letter (CRL) from the FDA for their New Drug Application for GA Depot 40mg. The companies are currently reviewing the CRL to determine their next steps.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 2:55 pm

BTCUSD

Former President Donald Trump, known for his preference for the U.S. dollar, admitted to engaging in transactions using Bitcoin, including a project involving the sale of limited edition sneakers. Despite his traditional views, Trump acknowledged the utility and growing acceptance of cryptocurrencies, indicating a more open stance towards them. He also praised Federal Reserve Chair Jerome Powell for his scandal-free tenure. Trump's comments suggest a warming attitude towards Bitcoin and cryptocurrencies.

Portfolio Pulse from Murtuza Merchant

March 11, 2024 | 2:55 pm

ACA

NOV

Arcosa Inc (NYSE:ACA) has agreed to acquire Ameron Pole Products, LLC from NOV Inc (NYSE:NOV) for $180 million in cash. Ameron, a manufacturer of engineered poles for infrastructure applications, reported $94 million in revenues and $20 million in Adjusted EBITDA for the year ended December 31, 2023. Arcosa plans to fund the acquisition with cash and borrowings, aiming to expand its product offerings in the lighting, traffic, and telecom sectors. The transaction is expected to close in Q2 2024. ACA shares dropped 1.02% to $83.86.

Portfolio Pulse from Shivani Kumaresan

March 11, 2024 | 2:48 pm

EQT

GNE

VTYX

U.S. stocks were lower on Monday, with the Dow Jones index falling over 150 points. EQT Corporation's shares dropped 8.4% after announcing a merger with Equitrans Midstream. Other notable declines include Ventyx Biosciences, MoneyLion Inc., Genie Energy Ltd., and several others, each falling due to various company-specific news such as clinical data reports, quarterly results, and strategic updates.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 2:37 pm

BLNK

Blink Charging Co. (NASDAQ:BLNK) announced the establishment of its global corporate headquarters and a new manufacturing facility in Bowie, Maryland. The new 15,000 square-foot headquarters and a 30,000 square-foot LEED Gold-certified production facility aim to increase manufacturing capacity to over 50,000 EV charging units annually, up from 15,000. This expansion supports Blink's commitment to sustainable transportation and the increasing demand for EV charging infrastructure. The move also includes the creation of the Blink Center of Charging Excellence, featuring vehicle interoperability testing, charger certification, and advanced R&D capabilities.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 2:35 pm

SLRN

Acelyrin Inc (NASDAQ:SLRN) announced positive results from its Phase 2b/3 trial of izokibep for Psoriatic Arthritis, meeting the primary endpoint with high statistical significance. The drug was well-tolerated, showing a favorable safety profile. Additionally, long-term data from a Phase 2b trial in hidradenitis suppurativa demonstrated no increased safety liability with longer-term treatment, with clinical improvements over time. SLRN shares rose 7.35% to $8.03.

Portfolio Pulse from Vandana Singh

March 11, 2024 | 2:32 pm